|
Thrombosis and Hemostasis
Citations 1-10 of 119 total displayed.
|
Most recent content
(12 Nov 2009):
|
Anti-CD3 antibodies modulate anti–factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy
- Baowei Peng, Peiqing Ye, David J. Rawlings, Hans D. Ochs, and Carol H. Miao
Blood 2009; 114: 4373-4382.
[Abstract]
[Full text]
[PDF]
The therapeutic effect of bone marrow–derived liver cells in the phenotypic correction of murine hemophilia A
- Neelam Yadav, Sumod Kanjirakkuzhiyil, Suresh Kumar, Manish Jain, Ashutosh Halder, Renu Saxena, and Asok Mukhopadhyay
Blood 2009; 114: 4552-4561.
[Abstract]
[Full text]
[PDF]
Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model
- Denise E. Sabatino, Christian Furlan Freguia, Raffaella Toso, Andrey Santos, Elizabeth P. Merricks, Haig H. Kazazian, Jr, Timothy C. Nichols, Rodney M. Camire, and Valder R. Arruda
Blood 2009; 114: 4562-4565.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 2009):
|
The pleiotropic role of the fibrinogen  ' chain in hemostasis
- Shirley Uitte de Willige, Kristina F. Standeven, Helen Philippou, and Robert A. S. Ariëns
Blood 2009; 114: 3994-4001.
[Abstract]
[Full text]
[PDF]
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII–specific immune responses in plasmid-mediated gene therapy–treated hemophilia mice
- Carol H. Miao, Benjamin R. Harmeling, Steven F. Ziegler, Benjamin C. Yen, Troy Torgerson, Liping Chen, Roger J. Yau, Baowei Peng, Arthur R. Thompson, Hans D. Ochs, and David J. Rawlings
Blood 2009; 114: 4034-4044.
[Abstract]
[Full text]
[PDF]
Characterization of complement factor H–related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
- Cynthia Abarrategui-Garrido, Rubén Martínez-Barricarte, Margarita López-Trascasa, Santiago Rodríguez de Córdoba, and Pilar Sánchez-Corral
Blood 2009; 114: 4261-4271.
[Abstract]
[Full text]
[PDF]
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives
- Anetta Undas, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydlowska, Agnieszka Skubiszak, Katarzyna Ciepluch, and Wieslawa Tracz
Blood 2009; 114: 4272-4278.
[Abstract]
[Full text]
[PDF]
Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity
- Henriët Meems, Alexander B. Meijer, David B. Cullinan, Koen Mertens, and Gary E. Gilbert
Blood 2009; 114: 3938-3946.
[Abstract]
[Full text]
[PDF]
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men
- Bas de Laat, Philip G. de Groot, Ronald H. W. M. Derksen, Rolf T. Urbanus, Koen Mertens, Frits R. Rosendaal, and Carine J. M. Doggen
Blood 2009; 114: 3656-3661.
[Abstract]
[Full text]
[PDF]
Crystal structure of protein Z–dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X
- Zhenquan Wei, Yahui Yan, Robin W. Carrell, and Aiwu Zhou
Blood 2009; 114: 3662-3667.
[Abstract]
[Full text]
[PDF]
|
|
